Schedule 13G ownership disclosure

PTC Therapeutics Inc

COMMON STOCK · CUSIP: 69366J200

Event date: 2026-09-30

Filing-level shares
5,512,555.00
Percent of class
6.6%
  • STATE STREET CORPORATION

    Shares: 5,512,555.00 · Class: 6.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000707
Form type
SCHEDULE 13G
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub